Treatment-related cardiovascular events in patients with non-small cell lung cancer: Evidence from real-world data with a competing risks approach.
Thi-Ngoc TranSanghee LeeHak Jin KimYoung Joo LeeThao Minh TuJin-Ho ChoiJae Won SongHyunsoon ChoPublished in: Cancer (2023)
Atrial fibrillation and flutter (AF) is the most common cardiovascular event, particularly at a high risk in patients with non-small cell lung cancer (NSCLC) undergoing surgery. Patients receiving surgery with poor performance status, diagnosed with regional stage, and undergoing lobectomy or pneumonectomy are at a high risk of AF. Systemic/radiotherapy is associated with cerebrovascular and ischemic heart disease in patients with NSCLC.
Keyphrases
- atrial fibrillation
- cardiovascular events
- minimally invasive
- coronary artery bypass
- small cell lung cancer
- catheter ablation
- left atrial
- oral anticoagulants
- coronary artery disease
- direct oral anticoagulants
- left atrial appendage
- percutaneous coronary intervention
- cardiovascular disease
- advanced non small cell lung cancer
- heart failure
- early stage
- surgical site infection
- electronic health record
- radiation therapy
- brain metastases
- type diabetes
- squamous cell carcinoma
- combination therapy
- big data
- data analysis
- drug induced
- mitral valve
- climate change
- replacement therapy
- machine learning